BBA
AXSM icon

Baader Bank Aktiengesellschaft’s Axsome Therapeutics AXSM Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$490K Buy
+2,000
New +$434K 0.04% 272
2026
Q1 		– Sell
-5,823
Closed -$1.06M – 428
2025
Q4 		$1.06M Buy
5,823
+3,708
+175% +$518K 0.07% 176
2025
Q3 		$252K Buy
+2,115
New +$238K 0.02% 411

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Baader Bank Aktiengesellschaft's AXSM Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 2,000 shares worth $490K. The stake represents 0.04% of the portfolio and ranks #272 among its holdings. This is a return to the name: Baader Bank Aktiengesellschaft previously reported a position in AXSM as recently as Q4 2025.

Baader Bank Aktiengesellschaft first reported a position in AXSM in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.06M in Q4 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Baader Bank Aktiengesellschaft held 2,000 shares of Axsome Therapeutics worth $490K as of Q2 2026.
  • Axsome Therapeutics was a new Baader Bank Aktiengesellschaft position in Q2 2026.
  • Axsome Therapeutics made up 0.04% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #272 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Axsome Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Baader Bank Aktiengesellschaft's Axsome Therapeutics position peaked at $1.06M in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.